OrbiMed Advisors »

Intra Cellular Therapies shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $14M 163k 83.52
2016-09-30 $1.4M 90k 15.26
2016-06-30 $34M 885k 38.82
2016-03-31 $8.2M 294k 27.80

More positions owned by OrbiMed Advisors

Boston Scientific Corporation (BSX)
Edgewise Therapeutics (EWTX)
Eli Lilly & Co. (LLY)
Sinovac Biotech SHS
Enliven Therapeutics (ELVN)
Alnylam Pharmaceuticals (ALNY)
Stryker Corporation (SYK)
Edwards Lifesciences (EW)
Intuitive Surgical Com New (ISRG)
Argenx Se Sponsored Adr (ARGX)
Sionna Therapeutics (SION)
Upstream Bio (UPB)
Disc Medicine (IRON)
Caris Life Sciences (CAI)
Silverback Therapeutics (SPRY)

View all positions for OrbiMed Advisors

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies